118th Congress · SENATE BILLBILL

S. 3220 — A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.

“A bill to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.”

Health

Introduced Nov 2, 2023

Last action Nov 2, 2023

Pipeline · Bill → Law

Step 1

Introduced

Nov 2, 2023

Step 2

Referred

Nov 2, 2023

HELP

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill expands the priority-review voucher program for tropical diseases to include coccidioidomycosis (also known as Valley fever). A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.

Provisions · 1 sectionsIntroduced in Senate

Timeline · 2 actions

Nov 2, 2023

Introduced in Senate

Nov 2, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.